Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 3/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27895146 | 0.85 | CYP1A2 (0.50) | CYP1A2CNR1NAAAEPHX1SIGMAR1 | |
| SCHEMBL30831714 | 0.84 | CYP1A2 (0.42) | CYP1A2CNR1NAAAEPHX1SIGMAR1 | |
| SCHEMBL5606779 | 0.81 | CYP1A2 (0.39) | CYP1A2CNR1NAAA | |
| SCHEMBL13517858 | 0.80 | CYP1A2 (0.38) | CYP1A2CNR1NAAAEPHX1SIGMAR1 | |
| SCHEMBL13517727 | 0.80 | CYP1A2 (0.38) | CYP1A2CNR1NAAA | |
| SCHEMBL10535680 | 0.79 | CYP1A2 (0.40) | CYP1A2 | |
| SCHEMBL5607285 | 0.79 | CYP1A2 (0.36) | CYP1A2CNR1NAAA | |
| SCHEMBL29028954 | 0.78 | CYP1A2 (0.48) | CYP1A2CNR1NAAAEPHX1SIGMAR1 | |
| SCHEMBL13517638 | 0.78 | CYP1A2 (0.37) | CYP1A2CNR1NAAAEPHX1SIGMAR1 | |
| SCHEMBL30831709 | 0.78 | CYP1A2 (0.43) | CYP1A2CNR1NAAAEPHX1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688908-A2 | CROSSLINKED POLYESTER ELASTOMERS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF | Momentive Performance Materials Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4688909-A1 | POLYESTER ELASTOMERS FROM DI-CARBOXYLIC ACID OR TRI-CARBOXYLIC ACID, MONO-CARBOXYLIC ACID, AND POLYOL FOR COSMETIC AND PERSONAL CARE APPLICATIONS | Momentive Performance Materials Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4626397-A1 | COSMETIC COMPOSITION FOR CARING KERATIN MATERIAL | L'OREAL (FR) | 2025-10-08 | — | — | EP | claimed |
| CN-116035949-B | Oil balance type low-turbidity high-compatibility cosmetic composition | 广州科创材料科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| US-20240382405-A1 | POLYESTER ELASTOMERS FROM DI-CARBOXYLIC ACID OR TRI-CARBOXYLIC ACID, MONOCARBOXYLIC ACID, AND POLYOL FOR COSMETIC AND PERSONAL CARE APPLICATIONS | MOMENTIVE PERFORMANCE MAT INC (US) | 2024-11-21 | — | — | US | claimed |
| CN-116211742-B | Microemulsion and preparation method thereof | 上海林清轩生物科技有限公司 | 2024-11-15 | — | — | CN | claimed |
| WO-2024206502-A2 | CROSSLINKED POLYESTER ELASTOMERS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2024-10-03 | — | — | WO | claimed |
| US-20240327571-A1 | CROSSLINKED POLYMER ELASTOMERS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF | MOMENTIVE PERFORMANCE MAT INC (US) | 2024-10-03 | — | — | US | claimed |
| WO-2024206504-A1 | POLYESTER ELASTOMERS FROM DI-CARBOXYLIC ACID OR TRI-CARBOXYLIC ACID, MONO-CARBOXYLIC ACID, AND POLYOL FOR COSMETIC AND PERSONAL CARE APPLICATIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2024-10-03 | — | — | WO | claimed |
| WO-2024113155-A1 | COSMETIC COMPOSITION FOR CARING KERATIN MATERIAL | L'OREAL (FR) | 2024-06-06 | — | — | WO | claimed |
| EP-2400951-A1 | TOPICAL FOAM COMPOSITION | Stiefel Research Australia Pty Ltd (AU) | 2012-01-04 | — | — | EP | claimed |
| EP-1671679-B1 | Cosmetic or dermatological composition in the form of a water-in-oil emulsion comprising phytosterols | SEBAPHARMA GMBH & CO KG (DE) | 2011-06-22 | — | — | EP | claimed |
| US-20100221194-A1 | TOPICAL FOAM COMPOSITION | MAYNE PHARMA LLC | 2010-09-02 | — | — | US | claimed |
| WO-2010096868-A1 | TOPICAL FOAM COMPOSITION | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2010-09-02 | — | — | WO | claimed |
| US-7776317-B2 | Glycerol ether mixture, cosmetic composition containing this mixture and process for its production | COGNIS IP MANAGEMENT GMBH (DE) | 2010-08-17 | — | — | US | claimed |
| US-20070292358-A1 | STORAGE-STABLE EMULSION SPRAY PRODUCT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-12-20 | — | — | US | claimed |
| EP-1824444-A1 | STORAGE-STABLE EMULSION SPRAY PRODUCT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-08-29 | — | — | EP | claimed |
| EP-1803660-A1 | Emulsion spray | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-07-04 | — | — | EP | claimed |
| WO-2006063726-A1 | STORAGE-STABLE EMULSION SPRAY PRODUCT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-06-22 | — | — | WO | claimed |
| EP-1671679-A1 | Cosmetic or dermatological composition in the form of a water-in-oil emulsion comprising phytosterols | Sebapharma GmbH & Co. KG (DE) | 2006-06-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240382405-A1 | POLYESTER ELASTOMERS FROM DI-CARBOXYLIC ACID OR TRI-CARBOXYLIC ACID, MONOCARBOXYLIC ACID, AND POLYOL FOR COSMETIC AND PERSONAL CARE APPLICATIONS | CUTA, DDC, ACMSD | CYP1A2 3076/4885CNR1 4178/4885NAAA 257/4885 |
| US-20070292358-A1 | STORAGE-STABLE EMULSION SPRAY PRODUCT | DGAT1, DLAT, FDFT1 | CYP1A2 1016/4885CNR1 3218/4885NAAA 2719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.